homepage_cover_1Firm of Choice for the Most Difficult Legal Issues homepage_cover_2Cross-Border Capabilities with a China Edge NewsFangda advised Kangh in reaching an exclusive license agreement with HilleVax for the Recombinant Hexavalent VLP Norovirus VaccineRead More InsightAntitrust China Annual Review 2023 Our annual review examines ten significant trends in China's antitrust landscape in 2023 and presents the forecasts for 2024.READ MORE Awards & RankingsThe Legal 500 Asia-Pacific 2024 Tier 1 RankingsChambers Greater China Region Guide 2023 Band 1 RankingsRead More